These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
59 related items for PubMed ID: 7841544
21. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells. Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM, Bates SE. Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959 [Abstract] [Full Text] [Related]
22. Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines. Benchekroun MN, Schneider E, Safa AR, Townsend AJ, Sinha BK. Mol Pharmacol; 1994 Oct; 46(4):677-84. PubMed ID: 7969046 [Abstract] [Full Text] [Related]
23. The multi-drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P-glycoprotein by an allosteric interaction. Martin C, Berridge G, Higgins CF, Callaghan R. Br J Pharmacol; 1997 Oct; 122(4):765-71. PubMed ID: 9375975 [Abstract] [Full Text] [Related]
24. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract. Limtrakul P, Khantamat O, Pintha K. Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030 [Abstract] [Full Text] [Related]
25. Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells. Chen G, Teicher BA, Frei E. Anticancer Res; 1996 Dec; 16(6B):3499-505. PubMed ID: 9042212 [Abstract] [Full Text] [Related]
26. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX, Yang XH. Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [Abstract] [Full Text] [Related]
27. New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors. Zhou XF, Zhang L, Tseng E, Scott-Ramsay E, Schentag JJ, Coburn RA, Morris ME. Drug Metab Dispos; 2005 Mar; 33(3):321-8. PubMed ID: 15585608 [Abstract] [Full Text] [Related]
28. Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins. Smith CD, Zilfou JT, Zhang X, Hudes GR, Tew KD. Cancer; 1995 May 15; 75(10):2597-604. PubMed ID: 7736407 [Abstract] [Full Text] [Related]
32. Circumvention of P-glycoprotein-mediated multiple drug resistance by phosphorylation modulators is independent of protein kinases. Smith CD, Zilfou JT. J Biol Chem; 1995 Nov 24; 270(47):28145-52. PubMed ID: 7499304 [Abstract] [Full Text] [Related]
33. Inhibitory effect of alkylating modulators on the function of P-glycoprotein. Yang JM, Sullivan GF, Makhey DB, LaVoie EJ, Hait WN. Oncol Res; 1997 Nov 24; 9(9):477-84. PubMed ID: 9495453 [Abstract] [Full Text] [Related]
38. Synthesis and structure of tolyporphin A O,O-diacetate. Wang W, Kishi Y. Org Lett; 1999 Oct 07; 1(7):1129-32. PubMed ID: 10825966 [Abstract] [Full Text] [Related]